why choose us

First received: October 09, 2022

Clinical Trial: Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Vulvovaginal Atrophy

Study Type: INTERVENTIONAL


Official Title: Effects of Local Dehydroepiandrosterone (DHEA) and Estradiol on Moderate to Severe Dyspareunia, a Symptom of Vulvovaginal Atrophy in Postmenopausal Women - a Randomized, Controlled Study

Brief Summary: Vulvovaginal atrophy (VVA) is a condition characterized by vaginal dryness, itching, burning, irritation and dyspareunia.The condition is mainly due to estrogen deficiency and is common during and after menopause.Furthermore, androgens may have an important function in these symptoms.The purpose of the study is to compare vaginal estrogen with vaginal dehydroepiandrosterone (DHEA, an androgen precursor) on dyspareunia (primary outcome), a symptom of VVA in postmenopausal women.Secondary outcomes are total symptom…

Read more